RE: Silence10 Feb 2024 18:35
I'm sure everyone here has noticed the phenomenon of an RNS which gives out 'middling' good news and the sp falls, presumably because people think "well, if that's the best they've got..." Maybe it's best just to wait for the *big one* and be patient if you have faith. The problem for the AVCT sp is that there are other cookies in the shop so people inevitably get tempted elsewhere (and why not) if the perception is that not much is happening with AVCT. It's a 'tension', as they say.
As for traders affecting the sp with FUD, I notice McMuff's figure: 'Share price chart showing... -6.7% 1 month' when there's been a notable absence of posting by someone whose thoughts I very much like to keep up on but some don't. And there is commonly much more positivity in posts on this BB than negativity anyway. I think controversial posters (I won't say unpopular as one recent post was recc'd >32 times when I looked a couple of days ago) are targeted out of a wish to grand-stand with their turn of phrase as much as anything else.
Liquid biopsies were mentioned by another poster here today. I've very recently listened to a presentation regarding liquid biopsies and an ADC treatment that targets HER2 expressing cancer cells. Apparently (and perhaps only in one cancer type, it wasn't clear) 25% of cancer cells express HER2 to a high level; 30% to a low level. And 30% / 40% don't express at all. So in that cancer type, if it's FAP expressing cancer, 70% of patients would benefit from AVA6K who otherwise would be unlikely to benefit from that ADC. And yes, 30% could strongly benefit from the ADC which is great for them ( –and perhaps the much cheaper AVA6K at the same time?).
Sign In
Follow the stocks
